TUS-21500-41687

3 vaccinations 3 coded responses 38 check-ins 3 free-text entries 3 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 481 / MI
Registered: 2020-12-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — day 7, dose 1
Feeling: Fair · Site: Itching · Fever · Headache

Adult check-in
2021-01-06
Survey response — day 14, dose 1
MedDRA: Musculoskeletal stiffness, Sciatica — Feeling: Good

Free text: Stiff neck that resolved in one daySciatica

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-08
Call successful
Does not wish to fill out VAERS report
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Survey response — 6 months, dose 2
MedDRA: Gestational hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Postpartum hypertension

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-20
Call 1 — Left Voicemail
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache · Be unable to do your normal daily activities

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-08
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-15
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-10-22
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-10-29
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-05
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-12
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-31
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-04-01
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-10-01
Survey response — 12 months, dose 3
MedDRA: Cutaneous T-cell lymphoma, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Cutaneous T Cell Lymphoma · Healthcare visit (other): Light therapy treatment

MedDRA releases: 2024-11 · check-in free text available
2022-10-01
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-10-03
Call 2 — Left Voicemail
2022-10-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

3 call center cases

1 successful · 2 unsuccessful

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Stiff neck that resolved in one daySciatica

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Postpartum hypertension

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: Cutaneous T Cell Lymphoma

Healthcare visit (other): Light therapy treatment

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Cutaneous T-cell lymphoma	·	·	✓
SD	Gestational hypertension	✓	✓	✓
SD	Musculoskeletal stiffness	✓	✓	✓
SD	Sciatica	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release